Literature DB >> 32359839

Symptomatic COVID-19 in Eye Professionals in Wuhan, China.

Chunyan Qiao1, Hui Zhang1, Mingguang He2, Guishuang Ying3, Changzheng Chen4, Yanping Song5, Julius Oatts6, Zhonghua Liu7, Yiqiao Xing8, Zefeng Xiao9, Min Ke10, Ya Ye5, Xiaoniao Chen1, Jihong Luo11, Ying Han12, Ningli Wang13.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32359839      PMCID: PMC7166011          DOI: 10.1016/j.ophtha.2020.04.026

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


× No keyword cloud information.
The novel coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had a global impact. Eye professionals may be at risk of contracting COVID-19 because face-to-face proximity is required to examine patients using a slit lamp or ophthalmoscope. Herein, we report the results of a cross-sectional case-control questionnaire survey conducted in the hospitals with eye professionals demonstrating symptomatic COVID-19 in Wuhan, China. The goal of this study was to understand the incidence of symptomatic COVID-19 among eye professionals and to improve their safety as the pandemic grows. The survey was conducted from February 26 through March 20, 2020. Using the key informant method, we received a list of eye professionals with symptomatic COVID-19 diagnosed through February 29, 2020, from the Wuhan Ophthalmology Society. This list was confirmed by the chairman of each respective ophthalmology department. Cases were diagnosed and disease severity was graded by treating pulmonologists based on the latest diagnostic criteria. Control participants were selected randomly within each ophthalmology department where case(s) were identified using 3 to 4 control participants per case. All participants were ophthalmologists, ophthalmic nurses, or technicians who worked in an ophthalmology department and had been involved in patient care since the outbreak. The questionnaire, distributed to the participants through a link built into the WeChat program (Tencent Technology Co. Ltd, Shenzhen, China), included demographic information and information on personal protective equipment (PPE) and hand hygiene. After informed consent was obtained, all questionnaires were answered by the participants themselves with the exception of 2 participants: one who died and another who remained intubated through data collection. The study was conducted in accordance with the tenets of the Declaration of Helsinki and was approved by the institutional review board of Central Theater Command General Hospital. Through February 29, 2020, a total of 28 eye professionals from 10 hospitals contracted COVID-19 with pulmonary symptoms. This included 14 ophthalmologists, 12 ophthalmic nurses, and 2 ophthalmic technicians (Table 1 ). Eight patients (28.5%) demonstrated severe disease, including 3 deaths. All 3 deaths were ophthalmologists who had worked in the same hospital. Besides reverse-transcriptase polymerase chain reaction (RT-PCR) analysis, serum antibody tests also were used to diagnose COVID-19. Except for 2 patients who died before receiving serum antibody testing, all patients with negative RT-PCR results showed positive results for SARS-CoV-2 antibody. Only 5 patients (17.9%) had family members with symptomatic COVID-19.
Table 1

Characteristics of 28 Eye Professionals Infected with Symptomatic COVID-19 in Wuhan, China

Patient No.HospitalAge (yrs)GenderOccupationSubspecialtyYears in PracticeSeverityChest Computed Tomography FindingsSARS-CoV-2 Test Results
Antibody TestReverse-Transcriptase Polymerase Chain Reaction Nasopharyngeal Swab
2G31FOphthalmologistComprehensive< 5MildUnilateral infiltrationPositive
5A41FOphthalmologistComprehensive> 15MildBilateral infiltrationPositive
11D49MOphthalmologistRetina> 15MildBilateral infiltrationPositive
12G63MOphthalmologistRetina> 15DeathBilateral infiltrationNANegative
13G53MOphthalmologistAnterior segment> 15DeathBilateral infiltrationNANegative
15H47FOphthalmologistComprehensive> 15MildUnilateral infiltrationPositiveNegative
16F40MOphthalmologistComprehensive> 15MildBilateral infiltrationPositive
17B37MOphthalmologistRetina10–15MildBilateral infiltrationPositiveNegative
21B42FOphthalmologistCornea> 15MildBilateral infiltrationPositiveNegative
22C49FOphthalmologistCornea> 15MildBilateral infiltrationPositive
25G39FOphthalmologistComprehensive10–15MildUnilateral infiltrationPositiveNegative
26I70MOphthalmologistAnterior segment> 15SevereBilateral infiltrationPositive
27G34MOphthalmologistComprehensive5–10DeathBilateral infiltrationPositive
28J33MOphthalmologistComprehensive< 5MildBilateral infiltrationPositive
1D29FNurse5–10MildNormalPositive
3G35FNurse10–15MildBilateral infiltrationPositiveNegative
4G33FNurse10–15MildUnilateral infiltrationPositiveNegative
6D33FNurse10–15MildBilateral infiltrationPositiveNegative
7E34FNurse10–15MildBilateral infiltrationPositive
8E37FNurse> 15MildBilateral infiltrationPositive
9E39FNurse> 15SevereBilateral infiltrationPositiveNegative
10E32FNurse10–15SevereBilateral infiltrationPositiveNegative
14D59MTechnician> 15MildBilateral infiltrationPositive
18B37FNurse10–15MildBilateral infiltrationPositiveNot performed
19B32FNurse5–10MildBilateral infiltrationPositive
20B38FNurse> 15SevereBilateral infiltrationPositivenot done
23C67FTechnician> 15SevereBilateral infiltrationPositive
24D31FNurse5–10MildBilateral infiltrationPositive

COVID-19 = novel corona virus disease 2019; F = female; M = male; NA = not available; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.

Characteristics of 28 Eye Professionals Infected with Symptomatic COVID-19 in Wuhan, China COVID-19 = novel corona virus disease 2019; F = female; M = male; NA = not available; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2. Twenty patients (71.4%), including all severe patients except one, were diagnosed before February 7, 2020: 14 days after January 23, when Wuhan was locked down, the most commonly cited latency period of COVID-19 (Fig S1A, available at www.aaojournal.org). The overall incidence of symptomatic COVID-19 among eye professionals across 10 hospitals was 2.52% (95% confidence interval, 1.68%–3.63%). The incidence of COVID-19 in ophthalmologists was similar to that seen in ophthalmic nurses and technicians (Table S2, available at www.aaojournal.org). The 2 hospitals with the highest incidences (hospitals E and G) were tertiary referral centers clustered within 4.5 kilometers of the Huanan Seafood market, where early outbreak was reported in Wuhan (Fig S1B, available at www.aaojournal.org). All control participants showed no symptoms and negative RT-PCR results. Both case and control groups had similar gender distributions, ratios of ophthalmologists to ophthalmic staff, working environments, and PPE training for COVID-19 (P > 0.05). However, compared with the control group, patients in the case group were older (P = 0.01), had been in practice longer (P = 0.001), had higher rates of contact with confirmed or suspected COVID-19 patients (P = 0.002), and reported higher rates of lack of sleep (P = 0.008) and lack of PPE supply (P = 0.02) before January 20, 2020, when the personal protection was strictly required in regular clinics (Table 3 ). Both groups showed a significant increase in PPE use after January 20 (all P < 0.0001; Table S4, available at www.aaojournal.org). In addition, control participants more frequently avoided direct skin contact with patients by using gloves or cotton tips (P = 0.03).
Table 3

Comparison of Characteristics between Symptomatic COVID-19 Patients and Control Participants

CharacteristicsPatients (n = 26)Control Participants (n = 96)P Value
Age (yrs)0.01
 Mean ± SD40.8 ± 10.335.1 ± 5.5
 Range29–6726–52
Female gender, no. (%)19 (73.1)80 (83.3)0.26
Years of clinical practice, no. (%)0.001
 < 51 (3.9)14 (14.6)
 5–94 (15.4)32 (33.3)
 10–158 (30.8)31 (32.3)
 > 1513 (50.0)19 (19.8)
Occupation, no. (%)0.18
 Ophthalmologist12 (46.2)47 (49.0)
 Ophthalmic nurse12 (46.2)48 (50.0)
 Ophthalmic technician2 (7.7)1 (1.0)
Workplace environment, no. (%)
 Outpatient clinic14 (53.9)57 (59.4)0.66
 Inpatient wards13 (50.0)54 (56.3)0.65
 Front line9 (4.6)30 (31.3)0.81
Contact with COVID-19 patient, no. (%)22 (84.6)48 (50.0)0.002
Lack of PPE, no. (%)14 (53.9)26 (27.1)0.02
No sufficient sleep, no. (%)11 (42.3)16 (16.7)0.008
Received COVID-19 PPE training, no. (%)20 (76.9)79 (82.3)0.58

COVID-19 = novel corona virus disease 2019; PPE: personal protective equipment; SD = standard deviation.

Boldface indicates statistical significance.

Two-sample t test for comparison of means and Fisher exact test for comparison of proportions.

Comparison of Characteristics between Symptomatic COVID-19 Patients and Control Participants COVID-19 = novel corona virus disease 2019; PPE: personal protective equipment; SD = standard deviation. Boldface indicates statistical significance. Two-sample t test for comparison of means and Fisher exact test for comparison of proportions. Generally, ophthalmologists might have been considered to be a low-risk subspecialty in the pandemic. However, our data showed at least a similar risk of symptomatic COVID-19 among eye professionals when compared with healthcare workers in general in Wuhan. Extrapolated from data available from the Chinese Red Cross Foundation and Wuhan Health Commission, , we estimated that the overall COVID-19 incidence among all healthcare workers in the 10 hospitals was 2.27% (713 contracted health workers of 31 367). The incidence of symptomatic COVID-19 and associated severe cases or death peaked during the early phase of the pandemic and decreased significantly 2 weeks after the lockdown, consistent with the incidence curve of symptomatic COVID-19 among healthcare workers in Wuhan. During the city’s lockdown, only urgent cases were seen in eye clinics, leading to less SARS-CoV-2 exposure for eye professionals. This observed clustering effect seems to support the effectiveness of stopping transmission and controlling disease spread. Given the risk of COVID-19 among the eye professionals, PPE use is highly recommended. After using PPE, only 2 new symptomatic COVID-19 cases were reported in hospitals E and G (those closest to Wuhan Seafood market), compared with 9 cases before using PPE. Older age, lack of PPE, lack of sufficient sleep, and less diligent hand hygiene were the risk factors for symptomatic COVID-19 contraction in this study. Our study has several limitations. First, providers with symptomatic COVID-19 were identified through contact with key informants. Ascertainment bias can inflate the proportion of severe cases by missing those asymptomatic or mildly symptomatic cases. Thus, results from this study apply only to symptomatic COVID-19 among eye professionals. Second, although control participants showed negative RT-PCR results, SARS-CoV-2 antibody tests were not performed; as such, we cannot rule out the possibility of asymptomatic COVID-19 among control participants. In addition, recall bias is an important concern in studies based on questionnaire data, with a risk of affected individuals overreporting symptoms, inadequate PPE, and hand hygiene. In conclusion, this study reported the incidence of symptomatic COVID-19 among eye professionals in Wuhan, China, and demonstrated that decrease in patient volume coinciding with city lockdown, adequate PPE, and diligent hand hygiene are important in preventing disease transmission.
  1 in total

1.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

  1 in total
  17 in total

1.  Unmasking the mask: the role of personal protective equipment for ophthalmologists caring for asymptomatic patients during the COVID-19 pandemic.

Authors:  Adrian T Fung
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

2.  Response to Letter to the Editor

Authors:  Banu Bozkurt; Sait Eğrilmez; Tomris Şengör; Özlem Yıldırım; Murat İrkeç
Journal:  Turk J Ophthalmol       Date:  2020-06-27

Review 3.  The ocular surface, coronaviruses and COVID-19.

Authors:  Mark Dp Willcox; Karen Walsh; Jason J Nichols; Philip B Morgan; Lyndon W Jones
Journal:  Clin Exp Optom       Date:  2020-05-13       Impact factor: 2.742

Review 4.  Ocular Involvement in Coronavirus Disease 2019: Up-to-Date Information on Its Manifestation, Testing, Transmission, and Prevention.

Authors:  Ziyan Chen; Gang Yuan; Fang Duan; Kaili Wu
Journal:  Front Med (Lausanne)       Date:  2020-11-30

5.  Preventive Practices of Ophthalmologists During COVID-19 Pandemic.

Authors:  Amjad Ali Omar Syed; Saulat Jahan; Alaa Ali Aldahlawi; Eihab Ali Alghazzawi
Journal:  Clin Ophthalmol       Date:  2021-03-23

6.  Quantitative Evaluation of Aerosol Generation from Non-contact Tonometry and its Correlation with Tear Film Characteristics.

Authors:  Weiting Hao; Jianhui Wu; Xinheng Zhao; Danni Liang; Xingchen Yu; Huazheng Cao; Yan Wang
Journal:  Adv Ther       Date:  2021-04-28       Impact factor: 3.845

7.  Incidence of COVID-19 among ophthalmology professionals.

Authors:  Javier Lacorzana; Santiago Ortiz-Perez; Marina Rubio Prats
Journal:  Med Clin (Engl Ed)       Date:  2020-08-03

8.  Restructuring Wet Age-Related Macular Degeneration Services During the COVID-19 Pandemic to Allow Social Distancing Outpatient Clinics (SDOC).

Authors:  Markus Groppe; Mandeep Singh Bindra
Journal:  Clin Ophthalmol       Date:  2021-02-17

9.  Progression of myopia in a natural cohort of Chinese children during COVID-19 pandemic.

Authors:  Dandan Ma; Shifei Wei; Shi-Ming Li; Xiaohui Yang; Kai Cao; Jianping Hu; Sujie Fan; Lihua Zhang; Ningli Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-07-21       Impact factor: 3.117

Review 10.  COVID-19: Ocular Manifestations and the APAO Prevention Guidelines for Ophthalmic Practices.

Authors:  Raymond L M Wong; Daniel S W Ting; Kelvin H Wan; Kenny H W Lai; Chung-Nga Ko; Paisan Ruamviboonsuk; Suber S Huang; Dennis S C Lam; Clement C Y Tham
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2020 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.